Stay updated on Pembrolizumab + Radiation in SCCHN Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Radiation in SCCHN Clinical Trial page.

Latest updates to the Pembrolizumab + Radiation in SCCHN Clinical Trial page
- Check4 days agoChange DetectedA site-wide banner announces NIH updates about replacing the term “Artificial Intelligence” with “Super Intelligence” during a transition. The clinical study record itself remains inaccessible behind a 403 error.SummaryDifference1%

- Check11 days agoChange DetectedThe footer's site revision indicator changes from v3.7.1 to v3.7.2; the page continues to display a 403 error.SummaryDifference0.2%

- Check18 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check38 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content, indicating the resource is inaccessible and preventing viewing the study details on this page.SummaryDifference19%

- Check59 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6. This indicates a small revision to the page metadata rather than substantive changes to the study data.SummaryDifference0.1%

- Check81 days agoChange DetectedAdded a page revision tag: Revision: v3.6.5. Removed several study-related items (e.g., Study Protocol and Statistical Analysis Plan, PubMed-linked publications) and related footer/navigation blocks from the page.SummaryDifference17%

Stay in the know with updates to Pembrolizumab + Radiation in SCCHN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Radiation in SCCHN Clinical Trial page.